Consolidated Planning Corp’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,150
Closed -$904K 178
2025
Q4
$904K Sell
11,150
-8,236
-42% -$709K 0.09% 128
2025
Q3
$1.7M Buy
19,386
+9,293
+92% +$830K 0.18% 111
2025
Q2
$838K Sell
10,093
-1,193
-11% -$99.7K 0.11% 125
2025
Q1
$947K Buy
+11,286
New +$1.05M 0.13% 113

Other funds holding LMAT

Consolidated Planning Corp's LMAT Position: Q1 2026 in Review

Consolidated Planning Corp sold out of LeMaitre Vascular (LMAT) in Q1 2026, closing a stake of 11,150 shares — an estimated $904K sold.

Consolidated Planning Corp first reported a position in LMAT in Q1 2025 and held it in 4 quarters. The position peaked at $1.7M in Q3 2025. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Consolidated Planning Corp reported no remaining LeMaitre Vascular position as of Q1 2026 after selling out during the quarter.
  • Consolidated Planning Corp sold 11,150 LeMaitre Vascular shares in Q1 2026, an estimated $904K.
  • Consolidated Planning Corp first reported a position in LeMaitre Vascular in Q1 2025 and held it in 4 quarters.
  • Consolidated Planning Corp's LeMaitre Vascular position peaked at $1.7M in Q3 2025.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Consolidated Planning Corp's 13F filing for Q1 2026, filed 16 Apr 2026.